Harnessing Brain's Plasticity Key to Treating Neurological Damage

The need for strategies that treat complex neurological impairments has never been greater.

One tack being pursued ...   more »

Health-related quality of life in a population-based sample of people with multiple sclerosis in Stockholm County.

Department of Clinical Neuroscience,

Division of Neurology,

Karolinska ...   more »

Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in MS

Oxford Centre for Enablement,

Windmill Road,

Oxford OX3 ...   more »

The scope and nature of pain in persons with multiple sclerosis.

Department of Rehabilitation Medicine,

Box 359740,

325 9th Avenue,

University of Washington School ...   more »

Serum immunologic markers in multiple sclerosis patients on continuous combined therapy with beta-interferon 1a, prednisone, and azathioprine.

Indiana Center for Multiple Sclerosis and Neuroimmunopathologic ...   more »

Disease evolution in multiple sclerosis.

University Dept.  of Clinical Neurology,

Radcliffe Infirmary,

Woodstock Road,

Oxford OX2 6HE,

United Kingdom,

Multiple sclerosis ...   more »

Cervical cord magnetization transfer ratio and clinical changes over 18 months in patients with RRMS: a preliminary study.

Department of Neurology,

Neuroimaging Research Unit, ...   more »

Glatiramer acetate in primary progressive multiple sclerosis:

Results of a multinational, multi-center, double-blind, placebo-controlled trial.

 OBJECTIVE:

To determine whether glatiramer acetate (GA) ...   more »

Improvements in muscle-tendon properties are beneficial to balance in MS.

Institute for Biophysical and Clinical Research into Human Movement,

Manchester Metropolitan University,

Hassall ...   more »

A comparison of interferon beta therapies for RRMS.
 

Dept. of Neurology,

Cologne City Hospitals,

University of Colognen, Ostmerheimerstr. 200, 51109,

Cologne, Germany

Interferon beta ...   more »

Naltrexone

(nal trex' one)

From:

SafeMedication.com

Other Names:ReVia
Important Warning

Large doses of naltrexone may cause liver failure. Tell your doctor if you have ...   more » Leave Comment  |  Permanent Link  |  Cosmos Monday, February 19   Patient Advocates With MS Fund Clinical Trial by All About MS on Mon 19 Feb 2007 12:00 AM CST Patient Advocates With MS Fund Clinical Trial Of  Promising Drug That Has Already Helped Thousands Over the last decade, anecdotal reports suggested that a very ...   more » Leave Comment  |  Permanent Link  |  Cosmos Sunday, February 18   MS: Extent of Brain Involvement at Diagnosis May Predict Later Brain Atrophy by All About MS on Sun 18 Feb 2007 12:00 AM CST MS: Extent of Brain Involvement at Diagnosis May Predict Later Brain  Atrophy CHICAGO, IL -- February 13, 2007 -- In patients with recently  diagnosed multiple ...   more » Leave Comment  |  Permanent Link  |  Cosmos Thursday, February 15   video - Tysabri by All About MS on Thu 15 Feb 2007 09:33 AM CST An MS Drug Back on the Market   After being suspended from the market for safety reasons, natalizumab is again available for the treatment of ...   more » Leave Comment  |  Permanent Link  |  Cosmos Sunday, February 11   SRI to Evaluate Drug for Treatment of Multiple Sclerosis by All About MS on Sun 11 Feb 2007 11:00 AM CST SRI to Evaluate Drug for Treatment of Multiple Sclerosis and Other Disorders Such as Rheumatoid Arthritis and Atherosclerosis   SRI International and Telik Announce Exclusive ...   more » Leave Comment  |  Permanent Link  |  Cosmos